{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:32:53Z","timestamp":1791113573141,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4084,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1111\/j.1523-1755.2004.00913.x","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T18:39:43Z","timestamp":1095187183000},"page":"1493-1502","source":"Crossref","is-referenced-by-count":142,"title":["Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats"],"prefix":"10.1016","volume":"66","author":[{"given":"Genro","family":"Fujisawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0010","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI111523","article-title":"Stractural-functional relationships in diabetic nephropathy","volume":"74","author":"Mauer","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ki.1991.57","article-title":"The renal tubulo-interstitium in diabetes mellitus","volume":"39","author":"Ziyadeh","year":"1991","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.HYP.0000056769.73726.E5","article-title":"Na\/H exchange isoform 1 is involved in mineralocorticoid induced cardiac injury","volume":"41","author":"Fujisawa","year":"2003","journal-title":"Hypertension"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","article-title":"Reversal of cardiac and renal fibrosis by pirfenidine and spironolactone in streptozotocin-diabetic rats","volume":"133","author":"Miric","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0040","first-page":"F1094","article-title":"Renal hypertrophy is associated with upregulation of TGF-\u03b21 gene expression in diabetic BB rat and NOD mouse","volume":"267","author":"Sharma","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diab.45.4.522","article-title":"Neutralization of TGF-\u03b2 by anti-TGF-\u03b2 antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice","volume":"45","author":"Sharma","year":"1996","journal-title":"Diabetes"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ki.1994.291","article-title":"Expression of transforming growth factor-\u03b21 during diabetic renal hypertrophy","volume":"46","author":"Shankland","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.19.10.1113","article-title":"Elevated plasma levels of transforming growth factor-\u03b21 in NIDDM","volume":"19","author":"Pfeiffer","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2337\/diab.46.3.473","article-title":"Expression of transforming growth factor-\u03b2 and Type IV collagen in early streptozotocin-induced diabetes","volume":"46","author":"Park","year":"1997","journal-title":"Diabetes"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/diab.42.3.450","article-title":"mRNA expression of growth factors in glomeruli from diabetic rats","volume":"42","author":"Nakamura","year":"1993","journal-title":"Diabetes"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ki.1995.139","article-title":"Cellular events in the evolution of experimental diabetic nephropathy","volume":"47","author":"Young","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2337\/diabetes.47.3.414","article-title":"Expression of transforming growth factor-\u03b21 and type IV collagen in the renal tubulointerstitium in experimental diabetes","volume":"47","author":"Gilbert","year":"1998","journal-title":"Diabetes"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s001250051648","article-title":"Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats","volume":"44","author":"Hill","year":"2001","journal-title":"Diabetologia"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.cb.04.110188.000521","article-title":"Cell-associated plasminogen activation: Regulation and physiologic functions","volume":"4","author":"Saksela","year":"1988","journal-title":"Annu Rev Cell Biol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI118396","article-title":"Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene","volume":"97","author":"Eitzman","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0095","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1152\/ajprenal.00032.2002","article-title":"Plasminogen activator inhibitor-1 and the kidney","volume":"283","author":"Eddy","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0100","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/ki.1992.442","article-title":"Glomerular matrix accumulation is linked to inhibition of the plasmin protease system","volume":"42","author":"Tomooka","year":"1992","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI117809","article-title":"Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells","volume":"95","author":"Vaughan","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.CIR.90.1.362","article-title":"Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells","volume":"90","author":"Van Leeuwen","year":"1994","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ki.1997.96","article-title":"Dual effects of angiotensin II on the plasminogen\/plasmin system in rat mesangial cells","volume":"51","author":"Kagami","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0120","first-page":"336","article-title":"Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production","volume":"85","author":"Brown","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/jmcc.1999.1053","article-title":"Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis","volume":"32","author":"Katoh","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1523-1755.2000.00160.x","article-title":"Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo","volume":"58","author":"Nakamura","year":"2000","journal-title":"Kidney Int"},{"issue":"Suppl","key":"10.1111\/j.1523-1755.2004.00913.x_bb0135","first-page":"S79","article-title":"Macrophages in renal injury","volume":"45","author":"Nikolic-Paterson","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(98)01346-4","article-title":"Pathogenesis, prevention, and treatment of diabetic nephropathy","volume":"352","author":"Cooper","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0145","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1084\/jem.158.6.1836","article-title":"Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity","volume":"158","author":"Baud","year":"1983","journal-title":"J Exp Med"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ki.1995.139","article-title":"Cellular events in the evolution of experimental diabetic nephropathy","volume":"47","author":"Young","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0155","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.1523-1755.2000.00311.x","article-title":"Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesion of human diabetic nephropathy","volume":"58","author":"Wada","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0160","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ndt\/17.6.985","article-title":"Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats","volume":"17","author":"Kelly","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/mvre.1998.2107","article-title":"Cellular mechanism of diabetic vascular hypertrophy","volume":"57","author":"Vranes","year":"1999","journal-title":"Microvasc Res"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/1056-8727(95)80026-B","article-title":"Vascular changes in diabetic kidney: Effects of ACE inhibition","volume":"9","author":"Vranes","year":"1995","journal-title":"J Diabetes Complication"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0175","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.HYP.22.5.754","article-title":"Early interstitial changes in hypertension-induced renal injury","volume":"22","author":"Mai","year":"1993","journal-title":"Hypertension"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0180","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0185","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.ASN.0000064701.70231.3F","article-title":"Urokinase receptor modulatescellular and angiogenic responses in obstructive nephropathy","volume":"14","author":"Zhang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0190","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ki.1994.291","article-title":"Expression of transforming growth factor-\u03b21 during diabetic renal hypertrophy","volume":"46","author":"Shankland","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-5347(05)66144-7","article-title":"Protective role of enalapril for chronic tubulointerstitial lesion of hyperoxaluria","volume":"166","author":"Toblli","year":"2001","journal-title":"J Urology"},{"issue":"Suppl 2","key":"10.1111\/j.1523-1755.2004.00913.x_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diab.32.2.S64","article-title":"The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy","volume":"32","author":"Mogensen","year":"1983","journal-title":"Diabetes"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0205","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s001250050752","article-title":"Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment","volume":"40","author":"Rasch","year":"1997","journal-title":"Diabetologia"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0210","first-page":"F704","article-title":"High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule","volume":"259","author":"Ziyadeh","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0215","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0220","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","article-title":"Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: Role of endothelin-1","volume":"15","author":"Park","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodelling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0235","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ki.1995.15","article-title":"Internephron heterogeneity of growth factors and sclerosis-modulation of platelet derived growth factor by angiotensin II","volume":"47","author":"Tanaka","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0245","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/ki.1994.215","article-title":"Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney","volume":"45","author":"Kaneto","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0250","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1997.20","article-title":"Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibitors","volume":"51","author":"Oikawa","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0255","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2307\/3578243","article-title":"Treatment of radiation nephropathy with captopril","volume":"132","author":"Cohen","year":"1992","journal-title":"Radiat Res"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.CIR.93.6.1073","article-title":"Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta","volume":"93","author":"Hamdan","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0265","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1523-1755.1999.00643.x","article-title":"Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats","volume":"56","author":"Kato","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0270","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","article-title":"Effect of activation and inhibition of the renin angiotensin system on plasma PAI-1 in humans","volume":"32","author":"Brown","year":"1998","journal-title":"Hypertension"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0275","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induced renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0280","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2004.00913.x_bb0285","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"activation of cardiac aldosterone production in rat myocardial infarction. effect of angiotensin ii receptor blockade and role in cardiac fibrosis","volume":"99","author":"Silvestre","year":"1999","journal-title":"circulation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815502172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815502172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T15:36:26Z","timestamp":1656171386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815502172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0085253815502172"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00913.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}